FDA Guidance on Discontinuance or Interruption Notification: Specific Aspects
The article highlights the aspects related to the definition of shortage and the steps the authority takes to mitigate the associated risks.
The article highlights the aspects related to the definition of shortage and the steps the authority takes to mitigate the associated risks.
The new article provides additional details regarding specific aspects associated with remote regulatory assessments.
The article highlights the critical points associated with the existing regulatory framework for remote regulatory assessments.
The new article covers some specific aspects associated with the evidential expectations for implantable devices, such as human factors, clinical performance testing, and labeling.
The article outlines the general considerations for evidentiary expectations and describes in detail the authority’s non-clinical recommendations.
The article highlights the key points associated with the concept of evidentiary expectations in the context of marketing submissions.